Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	-0,24%	+1,85%	+3,13%	+8,40%	49,74 mld.
REVOLUTION MEDICINES, INC.	-1,04%	-0,02%	+414,46%	+588,97%	40,49 mld.
BEONE MEDICINES AG	-2,86%	+3,14%	+22,67%	+55,76%	34,35 mld.
IQVIA HOLDINGS INC.	-2,36%	-0,44%	+23,01%	-7,80%	34,75 mld.
CELLTRION, INC.	-0,79%	+2,02%	+3,83%	+36,42%	26,98 mld.
ASCENDIS PHARMA A/S	+2,50%	+2,14%	-	-	16,58 mld.
MEDPACE HOLDINGS, INC.	-3,08%	-2,96%	+63,57%	+118,16%	15,6 mld.
IONIS PHARMACEUTICALS, INC.	-2,26%	+6,12%	+103,29%	+101,15%	14,27 mld.
EUROFINS SCIENTIFIC SE	-2,70%	-2,04%	+12,37%	+17,77%	13,76 mld.
Gemiddelde	-1,45%	+3,99%	+80,79%	+114,85%	27,39 mld.
Gewogen gemiddelde per kap.	-1,63%	+4,37%	+92,43%	+132,31%